Commercialising T cell receptor-based immunotherapy for multiple indications.
Investors 2
| Date | Name | Website |
| 23.12.2024 | Oxford Uni... | innovation... |
| 27.06.2024 | Syncona Pa... | synconaltd... |
Mentions in press and media 1
| Date | Title | Description |
| - | Yellowstone Biosciences | “Yellowstone Bio” |